HealthLeaders Media August 3, 2021
Scott Mace

Former Allscripts CEO and Livongo founder now heads Transcarent, touted as a comprehensive platform for employees of self-insured employers.

Glen Tullman is a serial entrepreneur in the digital healthcare business.

After leaving the CEO’s position at Allscripts in 2012, he founded Livongo, a diabetes monitoring and remote monitoring company acquired last year by Teladoc for $18.5 billion.

Now, Tullman is on to the next startup, Transcarent, which uses technology to improve how consumers engage with top healthcare providers. The platform is focused on employees of self-insured employers.

Tullman recently responded to HealthLeaders’ questions about how his latest startup intends to help self-insured employers navigate the virtual-care-dominated world of the COVID-19 pandemic.

HealthLeaders: What is consumer-directed healthcare, and how does it...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Health IT, Insurance, Interview / Q&A, Self-insured, Technology, Telehealth, Trends
Accolade Gets a Do-Over With Transcarent’s $621M Acquisition
Transcarent to buy Accolade for $621M
Transcarent to acquire fellow health benefits navigator Accolade for $621M
Transcarent To Acquire Accolade
Transcarent to acquire Accolade for $621 million

Share This Article